What does risk of future cancer mean to breast cancer patients?
- 6 March 2019
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 175 (3) , 579-584
Abstract
Purpose Newly diagnosed breast cancer patients greatly overestimate their risk of developing contralateral breast cancer (CBC). Better understanding of patient conceptions of risk would facilitate doctor–patient communication and surgical decision making. In this mixed methods study, we prospectively examined breast cancer patients’ perceived risk of future cancer and the reported factors that drove their risk perceptions. Methods Women age 21–60 diagnosed with breast cancer without a BRCA mutation or known distant metastases completed a study interview between surgical consult and surgical treatment. Participants completed a 12-item Perceived Risk Questionnaire, which assessed 10-year and lifetime risks of ipsilateral local recurrence, CBC, and distant recurrence. Patients provided qualitative explanations for their answers. Results Sixty-three patients completed study interviews (mean age 50.3). Participants were primarily White (85.7%) and 90.5% had attended college. Patients estimated their 10-year risk of CBC as 22.0%, nearly 4 times the established 10-year risk. Women attributed their risk perceptions to “gut feelings” about future cancer, even when women knew those feelings contradicted medically established risk. Perceptions of risk also reflected beliefs that cancer is random and that risk for local recurrence, CBC, and distant recurrence are the same. Conclusions Our findings point to the need for novel ways of presenting factual information regarding both risk of recurrence and of new primary cancers, as well as the necessity of acknowledging cognitive and affective processes many patients use when conceptualizing risk. By differentiating women’s intuitive feelings about risk from their knowledge of medically estimated risk, doctors can enhance informed decision making.Keywords
Funding Information
- the National Institutes of Health (R21 CA175950)
This publication has 30 references indexed in Scilit:
- The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancerBMJ Open, 2013
- Risky feelings: Why a 6% risk of cancer does not always feel like 6%Patient Education and Counseling, 2010
- Objective and Subjective Breast Cancer RiskCancer Nursing, 2010
- Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancersJournal of Experimental & Clinical Cancer Research, 2009
- Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast CancerJournal of Clinical Oncology, 2009
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Subjective and Objective Risk of Breast Cancer in Ashkenazi Jewish Individuals at Risk for BRCA1/2 MutationsGenetic Testing, 2004
- Supporting Informed Consumer Health Care Decisions: Data Presentation Approaches that Facilitate the Use of Information in ChoiceAnnual Review of Public Health, 2003
- The Evaluability Hypothesis: An Explanation for Preference Reversals between Joint and Separate Evaluations of AlternativesOrganizational Behavior and Human Decision Processes, 1996